Commercial Name: Trinex Active Ingredient: Triclabendazole Utilization: Used to treat liver flukes, specifically fascioliasis and paragonimiasis Available Dosages: 2mg
* Prices in the list do not apply to Switzerland, Sweden and Denmark. Customers are advised to place an order, and our team will contact back with updated prices.
Delivery information
We ship worldwide. There's a standard shipping fee of €15 for all products you order with us (FREE shipping for orders more than €200).
Guaranteed delivery time is 10-15 business days but in most cases we'll deliver your order within 5-10 calendar days.
Our stocks are located both within EU and oveaseas. Depending on your product and location, our Shipping Department makes proper arrangements to deliver your products within the guaranteed delivery time. Your products are shipped via International Registered Mail. Tracking numbers are provided within 1-3 working days after shipping.
Your parcel will only have your name and shipping address on it: we never mention our website, product type or name on the parcel, so that your order is 100% discreet and confidential.
Our guarantee policy includes a possibility of free reships if your order is incomplete/doesn't arrive on time/arrives in bad condition or products are ineffective.
Thank you! You will be the first to know this product becomes available again.
Description
Triclabendazole, manufactured by Novartis pharmaceuticals, is an antihelminthic drug that was approved by the FDA in February 2019 for the treatment of fascioliasis in humans. Fascioliasis is a parasitic infection often caused by the helminth, Fasciola hepatica, which is also known as “the common liver fluke” or “the sheep liver fluke” or by Fasciola gigantica, another helminth. These parasites can infect humans following ingestion of larvae in contaminated water or food.
Triclabendazole was previously used in the treatment of fascioliasis in livestock, but is now approved for human use. This drug is currently the only FDA-approved drug for individuals with fascioliasis, which affects 2.4 million people worldwide
Français
Deutsch
Italiano
Español
Čeština
العربية
